SAVENTIC HEALTH
AI-diagnosis of rare diseases
We have developed a pioneer ground-breaking solution that revolutionise
the diagnosis and identification of RDs for clinical trials or treatment. Our solution is implemented through two platforms:
SAVENTIC MED - designed for physicians and medical clinics, platform is integrating with existing IT systems (predefined tables' format) to analyse fully anonymized clinical data. Doctors receive a risk assessment for RDs with next steps and treatment options on the used hospital’s IT systems or directly from a medical coordinator from the hospital who cooperates with our company.
SAVENTIC CARE – designed for RD patients with health issues lasting +6 months seeking a diagnosis. Through the online platform, with a questionnaire and medical document upload feature, patients can easily provide their symptoms and receive a risk assessment for RD. High risk patients are supported by Saventics coordinator, doctors and referred to partnering clinics and specialists for further evaluation and treatment.
The system has been tested by +60 medical experts and implemented in +25 top cooperating clinics with +8 million patients examined in our database through our 2530 AI-driven RD algorithms with data from our 2 platforms for physicians and patients. Our innovation improves accuracy and efficiency in diagnosing RDs, faster identification of high-risk patients and better treatment outcomes.
BASIC INFORMATION
Contest Information
- DIAGNOSTIC ACCURACY. Our ground-breaking methodology has proven to be 15-20 times more effective than the current approach, enabling the development of new drugs quicker and cheaper, while providing faster treatment for a broader spectrum of RD patients.
- COST-EFFECTIVE AND COMPREHENSIVE. AI.D reduces diagnosis and treatment costs by streamlining the diagnostic process. Our comprehensive approach integrates AI with medical expertise and the most extensive patient database, offering unparalleled insights and reducing the misdiagnosis rate by even 90%. Additionally, our goal is to lower patient recruitment costs for clinical trials by 70%, making it a cost-effective solution for pharmaceutical and biotech companies.
- BROAD AND DEEP DATA UTILISATION. Our Saventic Care platform identifies and monitors RD patients through an online website, while the Saventic Med platform compiles and analyses all descriptive data from EHRs from hospitals for healthcare providers. By collaborating with medical clinics to structure and unify data, we create an innovative database that uncovers relationships between symptoms and diseases, adhering to local legal requirements.
- ADVANCED PREDICTIVE MODELS. The comprehensive database we build supports advanced models to predict symptoms and ensures thorough data verification. This database is crucial for creating and training algorithms that address all known RDs in the long term, providing a robust foundation for continued advancements in RD diagnosis.
- ENHANCED PATIENT ACCESS AND OUTCOMES. AI.D dramatically enhances patient access to treatments and clinical trials, boosting drug sales revenue and providing quicker therapeutic interventions. Our solution enables the screening of individual patients within seconds and the analysis of e.g. 300,000 patients within hours. Time efficiency is crucial in our plans to reduce patient dropout rates by 50%.
